Congress ramps up its scrutiny of drug compounding, putting FDA in a bind - STAT

Congress ramps up its scrutiny of drug compounding, putting FDA in a bind - STAT

STAT Plus: With safety and cash at stake, a squabble over drug compounding puts the FDA in a bind

By NICHOLAS FLORKO

ADOBE

Lawmakers are criticizing the way the FDA is handling the issue in letters and in reports, pushing the FDA to apply the law more forcefully or to back off.

READ MORE